Apotex
2 products tracked · names used in filings: Apotex, Apotex Europe BV
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 01 May 2026🇺🇸 FDA approval
FDA approves Evdi (trabectedin): new formulation or manufacturer
Apotex; NDA220837; New formulation or manufacturer; solution · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Evdi trabectedin | Approved | 2026-05-01 |
| 🇪🇺 | Olanzapine Apotex olanzapine | Withdrawn | 2010-06-10 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.